Afrocentric InvestmentJSE:ACT 52 Gross Margin % is 73.95% as of Dec. 2025, which is 0% above its 10-year median of 73.67. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 74.17% on this metric.
JSE:ACT's Gross Margin % is ranked better than 74.17% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs JSE:ACT: 65.46
Afrocentric Investment had a gross margin of 73.95% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Afrocentric Investment was -3.90% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Afrocentric Investment had a gross margin of 73.95% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Afrocentric Investment Gross Margin % Related Terms
Afrocentric Investment Gross Margin % Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ACT vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Afrocentric Investment (JSE:ACT) has a Gross Margin % of 73.95% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Afrocentric Investment and its competitors. This is near median its historical median of 73.67. Over the past decade, Afrocentric Investment's Gross Margin % has ranged from 54.27 to 77.92. According to the industry distribution chart, Afrocentric Investment ranks #163 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 25.8%.
Is Afrocentric Investment's Gross Margin % too high?
Afrocentric Investment's current Gross Margin % of 73.95% is near median its 10-year median of 73.67. Over the past 10 years, this metric has ranged from a low of 54.27 to a high of 77.92. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Afrocentric Investment's value of 73.95% is 84.5% above this industry median. Based on the distribution chart, Afrocentric Investment ranks #163 out of 631 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #163 out of 631 companies for Gross Margin %. This puts Afrocentric Investment in the upper half of its industry. The industry median Gross Margin % is 40.09. Afrocentric Investment's value of 73.95% is 84.5% above this benchmark. Historically, Afrocentric Investment's own Gross Margin % has ranged from 54.27 to 77.92 over the past decade. While the company's 10-year median is 73.67 vs. the industry median of 40.09, Afrocentric Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current Gross Margin % of 73.95% is 84.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Gross Margin % is 73.95%, which is near median its own 10-year median of 73.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Gross Margin % is 73.95%, which is near median its 10-year median of 73.67 and 84.5% above the Healthcare Providers & Services industry median of 40.09. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Gross Margin % is 73.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Gross Margin %: 73.95% (near median its 10-year median of 73.67)
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
Industry Position: 84.5% above the Healthcare Providers & Services median (#163 of 631)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
